Uchimoto, T., Tsuchida, S., Komura, K., Fukuokaya, W., Adachi, T., Hirasawa, Y., . . . Urabe, F. (2024). Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors. Targeted Oncology, 19(3), 401-411.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Uchimoto, Taizo, et al. "Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors."
Targeted Oncology 19, no. 3 (2024): 401-411.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Uchimoto, Taizo, et al. "Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors."
Targeted Oncology, vol. 19, no. 3, 2024, pp. 401-411.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.